Delivery Order SPE2DB22D3301-SPE2DB26FX4NM
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Ropivacaine 0.2% in 400 mg/200 mL vials with a ceiling value of $1,431.54. This is a firm fixed price delivery order with an ultimate completion date of August 28, 2025, and represents a non-competitive set-aside contract. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL) in 200 mL units, with a contract ceiling value of $6,988.89. This is a firm fixed price delivery order with an ultimate completion date of October 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded without a set-aside designation, indicating competitive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Ropivacaine 0.2% in a 400 mg/200 mL vial format with a contract ceiling value of $8,416.13 and firm fixed pricing. The order, which is expected to be completed by October 23, 2025, will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Ropivacaine 0.2% 400 mg/200 ml in 200 ml quantities, with a firm fixed price ceiling value of $1,908.72. The contract, which is a non-set-aside competitive award with an ultimate completion date of June 6, 2025, is performed from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ropivacaine 0.2% 400 mg/200 ml in 200 ml units, with a ceiling value of $2,147.31. This competitively awarded, firm fixed-price delivery order is set to be completed by September 19, 2025, with performance occurring at the vendor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's competitive standing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 ml in 200 ml units) at a ceiling value of $1,431.54. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The contract is performed out of the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 5, 2025. This delivery order is a child...
- AmerisourceBergen Drug Corp received a competitively awarded delivery order from the Defense Logistics Agency (DLA) on September 24, 2025, for the supply of Ropivacaine 0.2% (200 mg/100 mL) in 100 mL units, with a ceiling value of $1,419.66 and a firm fixed price structure. The contract is scheduled for ultimate completion on September 25, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order was issued with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $3,428.19 to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 ml in 200 ml units). This firm fixed-price delivery order is scheduled for completion by June 20, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award was made on a competitive basis with no set-aside designation, reflecting the vendor's established capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Ropivacaine 0.5% 150 mg/30 mL in 30 mL quantities, with a ceiling value of $5,786.97. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of May 13, 2025, and no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $5,112.84 delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Ropivacaine 0.2% 200 mg/100 mL in 100 mL quantities. This delivery order represents a firm fixed price contract with no set-aside designation, utilizing open competition. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 5, 2025. The delivery order is issued...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX4NMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 8, 2025, for the supply of Ropivacaine 0.2% 200 mg/100 mL in 100 mL vials, with a ceiling value of $1,241.69. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 10, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete in open federal procurement processes. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion vehicle extending through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a broad range of pharmaceutical products and medical commodities to support Defense Health Agency and other federal healthcare systems worldwide. The Ropivacaine procurement exemplifies the company's role in delivering critical medical supplies, including local anesthetics and other pharmaceuticals, essential for military medical operations and veteran healthcare services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/8/25 |